enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Tissue-type plasminogen activator - Wikipedia

   en.wikipedia.org/wiki/Tissue-type_plasminogen...

   However, many patients who were eligible for treatment were not treated. [14] [15] tPA has also been given to patients with acute ischemic stroke above age 90 years old. Although a small fraction of patients 90 years and above treated with tPA for acute ischemic stroke recover, most patients have a poor 30-day functional outcome or die. [16]

3. Alteplase - Wikipedia

   en.wikipedia.org/wiki/Alteplase

   Alteplase, sold under the brand name Activase among others, is a biosynthetic form of human tissue-type plasminogen activator (t-PA). It is a thrombolytic medication used to treat acute ischemic stroke, acute ST-elevation myocardial infarction (a type of heart attack), pulmonary embolism associated with low blood pressure, and blocked central venous catheter. [5]

4. Ozempic Is Part of New Stroke Prevention Guidelines ... - AOL

   www.aol.com/ozempic-part-stroke-prevention...

   And, for the first time, it includes the possibility of using a glucagon-like protein-1 (GLP-1) receptor agonist medication to lower the risk of heart disease and stroke.

5. Drugs like Ozempic may help lower 2nd stroke, heart attack risk

   www.aol.com/drugs-ozempic-may-help-lower...

   A new study says that type 2 diabetes medications GLP-1 agonists and SGLT2 inhibitors may help lower a stroke survivor’s risk of experiencing a subsequent stroke, heart attack, or death ...

6. Cerebroprotectant - Wikipedia

   en.wikipedia.org/wiki/Cerebroprotectant

   A cerebroprotectant (formerly known as a neuroprotectant) is a drug that is intended to protect the brain after the onset of acute ischemic stroke. [1] As stroke is the second largest cause of death worldwide and a leading cause of adult disability, over 150 drugs have been tested in clinical trials to provide cerebroprotection.

7. Antiplatelet drug - Wikipedia

   en.wikipedia.org/wiki/Antiplatelet_drug

   Prevention and treatment of arterial thrombosis is essential in patients with certain medical conditions whereby the risk of thrombosis or thromboembolism may result in disastrous consequences such as heart attack, pulmonary embolism or stroke. [3] Patients who require the use of antiplatelet drugs are: stroke with or without atrial ...